Tokyo Tape
Sign in
← CellSeed

Quarterly report · Q3

7776.TEDINET S100S7NI
Period2023-01-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥119m2023-01-01 → 2023-09-30StandaloneNet sales
Revenue¥126m2022-01-01 → 2022-12-31StandaloneNet sales (5-year summary)
Revenue¥88m2022-01-01 → 2022-09-30StandaloneNet sales
Operating income−¥577m2023-01-01 → 2023-09-30StandaloneOperating income
Operating income−¥564m2022-01-01 → 2022-09-30StandaloneOperating income
Ordinary income−¥587m2023-01-01 → 2023-09-30StandaloneOrdinary income
Ordinary income−¥754m2022-01-01 → 2022-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥571m2022-01-01 → 2022-09-30StandaloneOrdinary income
Profit before tax−¥584m2023-01-01 → 2023-09-30StandaloneIncome before income taxes
Profit before tax−¥572m2022-01-01 → 2022-09-30StandaloneIncome before income taxes
Net income−¥585m2023-01-01 → 2023-09-30StandaloneProfit loss
Net income−¥760m2022-01-01 → 2022-12-31StandaloneNet income loss (5-year summary)
Net income−¥574m2022-01-01 → 2022-09-30StandaloneProfit loss
Total assets¥2.6bnat 2023-09-30StandaloneAssets
Total assets¥1.5bnat 2022-12-31StandaloneAssets
Total assets¥1.5bnat 2022-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥390mat 2023-09-30StandaloneLiabilities
Total liabilities¥366mat 2022-12-31StandaloneLiabilities
Net assets / equity¥2.3bnat 2023-09-30StandaloneNet assets
Net assets / equity¥1.2bnat 2022-12-31StandaloneNet assets
Net assets / equity¥1.1bnat 2022-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥2.2bnat 2023-09-30StandaloneCash and deposits
Cash and deposits¥1.1bnat 2022-12-31StandaloneCash and deposits
EPS (basic)¥-20.952023-01-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-7.622023-07-01 → 2023-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-36.312022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-28.382022-01-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-9.82022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio84.4%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio74.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio71.3%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued30,889,419at 2023-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued24,422,619at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued22,159,419at 2022-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-09-30−¥147m
jpcrp040300-q3r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue2023-01-01 → 2023-09-30¥8m
jpcrp040300-q3r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue external2023-01-01 → 2023-09-30¥8m
jpcrp040300-q3r_E24158-000Cell Sheet Regenerative Medicinereportable segmentsegment profit2023-01-01 → 2023-09-30−¥394m
jpcrp040300-q3r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue2023-01-01 → 2023-09-30¥111m
jpcrp040300-q3r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue external2023-01-01 → 2023-09-30¥111m
jpcrp040300-q3r_E24158-000Laboratory Consumable Equipmentreportable segmentsegment profit2023-01-01 → 2023-09-30−¥36m
—segment totalrevenue2023-01-01 → 2023-09-30¥119m
—segment totalrevenue external2023-01-01 → 2023-09-30¥119m
—segment totalsegment profit2023-01-01 → 2023-09-30−¥430m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-09-30−¥147m
jpcrp040300-q3r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue2022-01-01 → 2022-09-30¥7m
jpcrp040300-q3r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue external2022-01-01 → 2022-09-30¥7m
jpcrp040300-q3r_E24158-000Cell Sheet Regenerative Medicinereportable segmentsegment profit2022-01-01 → 2022-09-30−¥347m
jpcrp040300-q3r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue2022-01-01 → 2022-09-30¥81m
jpcrp040300-q3r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue external2022-01-01 → 2022-09-30¥81m
jpcrp040300-q3r_E24158-000Laboratory Consumable Equipmentreportable segmentsegment profit2022-01-01 → 2022-09-30−¥70m
—segment totalrevenue2022-01-01 → 2022-09-30¥88m
—segment totalrevenue external2022-01-01 → 2022-09-30¥88m
—segment totalsegment profit2022-01-01 → 2022-09-30−¥418m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 307
ItemContextValueUnit
Asset retirement obligations nclCurrentQuarterInstant_NonConsolidatedMember33705000JPY
Other nclPrior1YearInstant_NonConsolidatedMember－JPY
Other nclCurrentQuarterInstant_NonConsolidatedMember5141000JPY
Noncurrent liabilitiesPrior1YearInstant_NonConsolidatedMember184887000JPY
Noncurrent liabilitiesCurrentQuarterInstant_NonConsolidatedMember183847000JPY
LiabilitiesPrior1YearInstant_NonConsolidatedMember365582000JPY
LiabilitiesCurrentQuarterInstant_NonConsolidatedMember389592000JPY
Capital stockPrior1YearInstant_NonConsolidatedMember1467377000JPY
Capital stockCurrentQuarterInstant_NonConsolidatedMember2290271000JPY
Capital surplusPrior1YearInstant_NonConsolidatedMember446957000JPY
Capital surplusCurrentQuarterInstant_NonConsolidatedMember1269852000JPY
Retained earningsPrior1YearInstant_NonConsolidatedMember-759680000JPY
Retained earningsCurrentQuarterInstant_NonConsolidatedMember-1344190000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember-227000JPY
Treasury stockCurrentQuarterInstant_NonConsolidatedMember-227000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember1154427000JPY
Shareholders equityCurrentQuarterInstant_NonConsolidatedMember2215705000JPY
Valuation difference on available for sale securitiesPrior1YearInstant_NonConsolidatedMember-321000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant_NonConsolidatedMember11649000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember-321000JPY
Valuation and translation adjustmentsCurrentQuarterInstant_NonConsolidatedMember11649000JPY
Subscription rights to sharesPrior1YearInstant_NonConsolidatedMember24232000JPY
Subscription rights to sharesCurrentQuarterInstant_NonConsolidatedMember23561000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember1178338000JPY
Net assetsCurrentQuarterInstant_NonConsolidatedMember2250917000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember1543920000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember2640509000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember88185000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember119202000JPY
Cost of salesPrior1YTDDuration_NonConsolidatedMember45405000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember52946000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember42780000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember66256000JPY
Research and development expenses sgaPrior1YTDDuration_NonConsolidatedMember333949000JPY
Research and development expenses sgaCurrentYTDDuration_NonConsolidatedMember390550000JPY
Other sgaPrior1YTDDuration_NonConsolidatedMember273300000JPY
Other sgaCurrentYTDDuration_NonConsolidatedMember252705000JPY
Selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember607250000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember643255000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember-564470000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-576999000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember10000JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember13000JPY
Foreign exchange gains noiPrior1YTDDuration_NonConsolidatedMember1993000JPY
Foreign exchange gains noiCurrentYTDDuration_NonConsolidatedMember1709000JPY
Other noiPrior1YTDDuration_NonConsolidatedMember201000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember117000JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember2204000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember1840000JPY
Interest expenses noePrior1YTDDuration_NonConsolidatedMember628000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2022-12-31pass
balance sheet identitynon_consolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-09-30pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-09-30pass